According to the recent research report titled ‘Europe Electrophysiology Market Size By Indication, By Product, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, Europe electrophysiology market is expected to surpass the USD 3.4 billion threshold by the year 2027.
 

Shifting preferences towards electrophysiology catheter ablation, technological advancements, and rising prevalence of atrial fibrillation are the key factors stimulating Europe electrophysiology market growth. Moreover, rising number of patients with cardiac disorders has resulted in high prevalence of heart strokes, which in turn is contributing towards the overall market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3212722/
 

Coming to the restraints, strict regulatory framework and hefty investment required for manufacturing EP devices are anticipated to impede the overall industry expansion during the study period.
 

The COVID-19 pandemic has had a negative impact on Europe electrophysiology market share due to lower volume of procedures conducting in a bid to prioritize treating individuals with Coronavirus. Several companies' product sales were hampered by the widespread infection rates, resulting in lower revenue growth.
 

Based on product type, EP diagnostic catheters segment held 35% of overall market revenue in 2020 and is expected to grow significantly through 2027, owing to mounting demand for intra-cardiac sensing, mapping, and recording as a result of rising diseases. Moreover, due to the widespread adoption of novel technologies in emerging countries, product advancements such as steerable curve electrophysiology diagnostic catheters will drive segment growth.
 

With respect to indication channel, the ventricular tachycardia segment is expected to register a CAGR of 13.5% over the study period, as it is one of the most common causes of cardiac failure, which adds to the rate of hospitalization. Growing use of novel and advanced technologies in the treatment of ventricular tachycardia, such as EP catheters will further boost the segmental expansion.
 

Moving on to end use scope, the catheterization laboratories segment held a significant portion of Europe electrophysiology industry share in 2020 and it is expected to record 13.3% CAGR over the coming years, creditable to increasing catherization procedures. Surging demand for cardiac ablation and diagnosis will also stimulate the product demand.
 

In addition, patient preferences will be influenced by the integration of advanced technologies and infrastructure growth, which will increase the number of electrophysiology procedures performed in laboratories in Europe.
 

Geographically, U.K. electrophysiology industry size is predicted to expand at a 12.2% CAGR through 2027, attributable to booming elderly population, escalating demand for advanced technologies, and rising diseases due to changing lifestyles.
 

Major players impacting Europe electrophysiology market trends are Siemens AG, Magnetecs Corporation, Medtronic plc, Johnson & Johnson, Koninklijke Philips N.V., Japan Lifeline Co. Ltd., GE Healthcare, Boston Scientific Corporation, Biotronik SE & Co. KG, and Abbott Laboratories.